Literature DB >> 3220101

Lactitol: gastrointestinal absorption and effect on blood lactate in healthy volunteers and patients with cirrhosis.

J Metzger1, C Chollet, M Wermeille, J Biollaz, J B Llull, B H Lauterburg.   

Abstract

The gastrointestinal absorption of lactitol has been studied in 6 healthy volunteers and 8 patients with cirrhosis. Following administration of lactitol 0.5 g/kg, no lactitol was found in serum. The urinary excretion of lactitol over 24 h ranged from 0.1 to 1.4% of the administered dose (0.46% in cirrhotics and 0.35% in healthy volunteers). Blood D- and L-lactate and plasma glucose did not increase following lactitol. The data indicate that lactitol was poorly absorbed from the gastrointestinal tract in healthy volunteers and patients with cirrhosis, and that the disaccharide did not disturb glucose or lactate homeostasis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3220101     DOI: 10.1007/bf00555516

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  7 in total

1.  Lactulose in the treatment of chronic portal-systemic encephalopathy. A double-blind clinical trial.

Authors:  S G Elkington; M H Floch; H O Conn
Journal:  N Engl J Med       Date:  1969-08-21       Impact factor: 91.245

2.  Food additives derived from lactose: lactitol and lactitol palmitate.

Authors:  J A van Velthuijsen
Journal:  J Agric Food Chem       Date:  1979 Jul-Aug       Impact factor: 5.279

3.  Lactitol in the treatment of chronic hepatic encephalopathy: an open comparison with lactulose.

Authors:  P L Lanthier; M Y Morgan
Journal:  Gut       Date:  1985-04       Impact factor: 23.059

4.  Lactitol, a new hydrogenated lactose derivative: intestinal absorption and laxative threshold in normal human subjects.

Authors:  D H Patil; G K Grimble; D B Silk
Journal:  Br J Nutr       Date:  1987-03       Impact factor: 3.718

5.  Lactitol versus lactulose in the treatment of chronic hepatic encephalopathy. A double-blind, randomised, cross-over study.

Authors:  M Y Morgan; K E Hawley; D Stambuk
Journal:  J Hepatol       Date:  1987-04       Impact factor: 25.083

6.  [The effect of lactitol on the production of expired hydrogen in normal subjects].

Authors:  M Griessen; R Bergoz; L Balant; E Loizeau
Journal:  Schweiz Med Wochenschr       Date:  1986-04-12

7.  Comparative modes of action of lactitol and lactulose in the treatment of hepatic encephalopathy.

Authors:  D H Patil; D Westaby; Y R Mahida; K R Palmer; R Rees; M L Clark; A M Dawson; D B Silk
Journal:  Gut       Date:  1987-03       Impact factor: 23.059

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.